Biopep Malaysia Sdn. Bhd.

Biopep Malaysia Sdn. Bhd. is a wholly-owned subsidiary of Biopep Solutions Inc., Canada. The parent company, Biopep Solutions Inc., Canada, discovers, develops and manufactures innovative therapeutic products for the treatment of human diseases. Biopep Malaysia focuses on the extraction of Leech Saliva Extract (LSE) from different species of leeches found in Malaysia to be used for treatment of several types of cancer. The parent company has successfully received US patent protection for its product, LSE, as a treatment for various types of cancers and has an additional pending patent for worldwide protection on the use of LSE to treat cancer.

It focuses its activity on BPS-001 production. In order to ensure a sustainable supply of Malaysian leeches, Hirudinaria manillensis, the raw material used for production of BPS-001, Biopep Malaysia had signed a MOA with HUSNA Hirudinaria Agro Farm (HUSNA) in March 2015. HUSNA operates a leech farm in Rawang, Selangor.

Biopep Malaysia had also signed a Lease with UPM (Universiti Putra Malaysia) – Malaysian Technology Development Corporation (MTDC) to secure a seven-unit premises for its incubator complex at the UPM-MTDC Technology Centre III at Serdang, Selangor. The production and manufacturing facilities include Administrative Offices, Laboratories for Leech Holding, Leech Saliva Extraction, and Quality Control, Production (Freeze Drying/Deep Freezing), pilot Leech Breeding facilities and R&D activities.